Afficher la couverture 'Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial | Trédan, Olivier' en grand format
/5

0 avis

Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial

Archive ouverte

Trédan, Olivier | Wang, Qiang | Pissaloux, Daniel | Cassier, Pierre | de La Fouchardière, Arnaud | Fayette, Jérôme | Desseigne, Françoise | Ray-Coquard, Isabelle | de La Fouchardière, Christelle | Frappaz, Didier | Heudel, Pierre, E. | Bonneville-Levard, Alice | Flechon, Aude | Sarabi, Mathieu | Guibert, Philippe | Bachelot, Thomas | Pérol, Maurice | You, Benoit | Bonnin, Nathalie | Collard, Olivier | Leyronnas, Cécile | Attignon, Valéry | Baudet, Christian | Sohier, Emilie | Villemin, Jean-Philippe | Viari, Alain | Boyault, Sandrine | Lantuejoul, Sylvie | Paindavoine, Sandrine | Treilleux, Isabelle | Rodriguez, Cécile | Agrapart, Vincent | Corset, Veronique | Garin, Gwenaelle | Chabaud, Sylvie | Perol, David | Blay, Jean-Yves

Edité par CCSD ; Elsevier -

International audience. Antitumor activity of molecular-targeted agents is guided by the presence of documented genomic alteration in specific histological subtypes. We aim to explore the feasibility, efficacy and therapeutic impact of molecular profiling in routine setting.

Consulter en ligne

Suggestions

Du même auteur

Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme

Archive ouverte | Varnier, Romain | CCSD

International audience. ObjectivesThe objectives of this study were to identify actionable genomic alterations in the gynaecological subpopulation of the ProfiLER programme and to report clinical efficacy of recomme...

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial

Archive ouverte | Bonneville-Levard, Alice | CCSD

International audience. Immunohistochemistry and recent molecular technologies progressively guided access to personalized anti-tumoral therapies. We explored the feasibility, efficacy, and the impact of molecular p...

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol.

Archive ouverte | Bernichon, E. | CCSD

International audience. Background: Breast cancer (BC) patients with comparable prognostic features have heterogeneous outcomes, party related to a possible radiotherapy resistance leading to local-regional recurren...

Chargement des enrichissements...